Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 832

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 832
---
,243 | ​ | ​ | ​ | ​          | $ | 48,983 | ​ | ​ | ​ | ​                       | $ | 82,678 | ​ | ​ | ​ | ​          | $ | 81,658 | ​ | ​ |
| One year to two years | ​ | ​ | ​                       | ​ |      — | ​ | ​ | ​ | ​          | ​ |      — | ​ | ​ | ​ | ​                       | ​ | 12,002 | ​ | ​ | ​ | ​          | ​ | 11,350 | ​ | ​ |
| Total                 | ​ | ​ | ​                       | $ | 49,243 | ​ | ​ | ​ | ​          | $ | 48,983 | ​ | ​ | ​ | ​                       | $ | 94,680 | ​ | ​ | ​ | ​          | $ | 93,008 | ​ | ​ |

All available-for-sale marketable securities are classified as marketable securities, current or marketable securities, non-current depending on the contractual maturity date of the individual available-for-sale security. Other income, net includes interest and dividends, accretion/amortization of discounts/premiums, realized gains and losses on sales of securities and credit loss expense due to declines in the fair value of securities, if any. The cost of securities sold is based on the specific identification method. There were no sales of available-for-sale marketable securities during the years ended December 31, 2023 and 2022. During the year ended December 31, 2021, the Company sold certain of its available-for-sale debt securities with a total fair value of $10,029, which resulted in realized gains of $39. As of December 31, 2023 and 2022, accrued interest receivables on our available-for-sale debt securities were $139 and $489, respectively. 4. Accumulated Other Comprehensive (Loss) Income The following table summarizes the changes in accumulated other comprehensive (loss) income, net of tax, from unrealized gains (losses) on available-for-sale marketable securities, the Company’s only component of accumulated other comprehensive (loss) income, for the years ended December 31, 2023, 2022 and 2021.

| ​                                                               | ​ | ​ | Total AccumulatedOther ComprehensiveIncome (Loss) |   |        |   | ​ |
|:----------------------------------------------------------------|:--|:--|:------------------------------------------------